Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celularity IncCELU · Entity 7145 | 10% owner | January 24, 2025 | January 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celularity Inc
Report date January 24, 2025 · Filed January 28, 2025
Jointly reported with Lim Kok Thay, Genting Berhad
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Dragasac Limited | 6,335,630 |
Last balance in matching sequence
After 2025-01-24 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-01-24 · Other · Acquired 535,274 · Balance 5,682,649 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Row 2 · 2025-01-24 · Other · Acquired 652,981 · Balance 6,335,630 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.49 · Expires 2029-01-16 | IndirectBy Dragasac Limited | 0 |
Reported balance
After 2025-01-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-01-24 · Other · Disposed 535,274 · Balance 0 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.07 · Expires 2029-01-16 | IndirectBy Dragasac Limited | 535,274 |
Reported balance
After 2025-01-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-01-24 · Other · Acquired 535,274 · Balance 535,274 F3: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.49 · Expires 2030-03-16 | IndirectBy Dragasac Limited | 0 |
Reported balance
After 2025-01-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-01-24 · Other · Disposed 652,981 · Balance 0 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.07 · Expires 2030-03-16 | IndirectBy Dragasac Limited | 652,981 |
Reported balance
After 2025-01-24 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-01-24 · Other · Acquired 652,981 · Balance 652,981 F3: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.07 · Expires 2029-01-16 | IndirectBy Dragasac Limited | 0 |
Reported balance
After 2025-01-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-01-24 · Other · Disposed 535,274 · Balance 0 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.07 · Expires 2030-03-16 | IndirectBy Dragasac Limited | 0 |
Reported balance
After 2025-01-24 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-01-24 · Other · Disposed 652,981 · Balance 0 F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 2,531 |
Reported balance
Holding disclosure · report date 2025-01-24 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,531 |
Filing footnotes · ownership attribution and instrument terms
F1: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split").
F2: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein.
F3: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 652,981 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 9 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 0 Underlying: Class A Common Stock · 652,981 shares Expires 2030-03-16 F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 535,274 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 8 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 0 Underlying: Class A Common Stock · 535,274 shares Expires 2029-01-16 F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 652,981 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 7 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 652,981 Underlying: Class A Common Stock · 652,981 shares Expires 2030-03-16 F3 · kind: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · price: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · balance_after: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 652,981 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 6 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 0 Underlying: Class A Common Stock · 652,981 shares Expires 2030-03-16 F1 · derivative.exercise_price: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · kind: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · price: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 535,274 | Not disclosed Strike: $2.07 | Not disclosed |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 5 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 535,274 Underlying: Class A Common Stock · 535,274 shares Expires 2029-01-16 F3 · kind: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · price: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · balance_after: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 535,274 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · derivative · entry 4 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 0 Underlying: Class A Common Stock · 535,274 shares Expires 2029-01-16 F1 · derivative.exercise_price: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · kind: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F3 · price: On January 24, 2025, the Issuer amended and restated the terms of the 652,981 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021, as well as the 535,274 warrants (as adjusted for the Reverse Stock Split) that Dragasac received in connection with a securities purchase agreement between the Issuer and Dragasac on January 12, 2024, in order to adjust the exercise price from $2.4898 per share of Class A Common Stock (as adjusted for the Reverse Stock Split) to $2.07 per share of Class A Common Stock. F1 · derivative.underlying_shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherClass A Common Stock | 652,981 | $2.07 | $1,351,670.67 |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · nonDerivative · entry 2 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 6,335,630 F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · balance_after: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 16:45 UTC | Celularity Inc CELU · Entity 7145 | OtherClass A Common Stock | 535,274 | $2.07 | $1,108,017.18 |
DisclosureSEC source: 0000905148-25-000224 · form4.xml · nonDerivative · entry 1 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 5,682,649 F1 · shares: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F1 · balance_after: These numbers have been adjusted to reflect the 1-for-10 reverse stock split the Issuer effected on February 28, 2024 (the "Reverse Stock Split"). F2 · ownership.nature: These securities are directly held by Dragasac Limited ("Dragasac"), which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 17:22 UTC | Celularity Inc CELU · Entity 7145 | PurchaseWarrants (Right to Buy) · Derivative | 16,500,000 | $0.13 Strike: $0.25 | $2,062,500.00 |
DisclosureSEC source: 0000905148-24-000212 · form4.xml · derivative · entry 6 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Resorts World Inc Pte. Ltd. Disclosed balance after: 16,500,000 Underlying: Class A Common Stock · 16,500,000 shares Expires 2029-01-16 F9 · derivative.exercise_price: The actual exercise price for these warrants is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F4 · kind: On January 12, 2024, the Issuer entered into a loan agreement with Resorts World Inc Pte. Ltd. ("RWI"), pursuant to which RWI provided a $15.0 million loan to the Issuer, net of an original issue discount representing the purchase price of the Tranche 1 Warrants and Tranche 2 Warrants (each defined herein), in exchange for an initial tranche of warrants to purchase up to 16,500,000 shares of Class A Common Stock (the "Tranche 1 Warrants") and a second tranche of warrants to purchase up to 13,500,000 shares of Class A Common Stock (the "Tranche 2 Warrants"). F5 · kind: The Tranche 2 Warrants are not exercisable until the later of (i) clearance from the Committee on Foreign Investment in the United States and (ii) July 16, 2024, and the exercise price of the Tranche 2 Warrants will be equal to the "Minimum Price" (as defined in Nasdaq Listing Rule 5635(d)) on the date they become exercisable. Accordingly, at this time, the Tranche 2 Warrants are not "derivative securities" (as such term is defined in Rule 16a-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) and are thus not reportable for purposes of Section 16 of the Exchange Act. F7 · ownership.nature: These warrants are held by RWI. Genting Berhad indirectly holds 50% of RWI with the balance 50% indirectly held by Mr. Lim. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 17:22 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 6,529,818 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0000905148-24-000212 · form4.xml · derivative · entry 5 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 6,529,818 Underlying: Class A Common Stock · 6,529,818 shares Expires 2030-03-16 F9 · derivative.exercise_price: The actual exercise price for these warrants is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F2 · kind: In connection with the Securities Purchase Agreement, the Issuer amended and restated the terms of the 6,529,818 warrants that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021 in order to adjust the exercise price from $6.77 per share of Class A Common Stock to $0.24898 per share of Class A Common Stock and to extend the expiration date to March 16, 2030. F2 · price: In connection with the Securities Purchase Agreement, the Issuer amended and restated the terms of the 6,529,818 warrants that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021 in order to adjust the exercise price from $6.77 per share of Class A Common Stock to $0.24898 per share of Class A Common Stock and to extend the expiration date to March 16, 2030. F6 · ownership.nature: These securities are directly held by Dragasac, which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 17:22 UTC | Celularity Inc CELU · Entity 7145 | OtherWarrants (Right to Buy) · Derivative | 6,529,818 | Not disclosed Strike: $6.77 | Not disclosed |
DisclosureSEC source: 0000905148-24-000212 · form4.xml · derivative · entry 4 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 0 Underlying: Class A Common Stock · 6,529,818 shares Expires not disclosed F2 · kind: In connection with the Securities Purchase Agreement, the Issuer amended and restated the terms of the 6,529,818 warrants that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021 in order to adjust the exercise price from $6.77 per share of Class A Common Stock to $0.24898 per share of Class A Common Stock and to extend the expiration date to March 16, 2030. F2 · price: In connection with the Securities Purchase Agreement, the Issuer amended and restated the terms of the 6,529,818 warrants that Dragasac received in connection with the merger of GX Acquisition Corp. and the Issuer on July 16, 2021 in order to adjust the exercise price from $6.77 per share of Class A Common Stock to $0.24898 per share of Class A Common Stock and to extend the expiration date to March 16, 2030. F3 · derivative.expiration_date: These warrants were scheduled to expire upon the earlier of (i) March 16, 2025, or (ii) the consummation of a change in control of the Issuer. F6 · ownership.nature: These securities are directly held by Dragasac, which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 17:22 UTC | Celularity Inc CELU · Entity 7145 | PurchaseWarrants (Right to Buy) · Derivative | 5,352,746 | $0.13 Strike: $0.25 | $669,093.25 |
DisclosureSEC source: 0000905148-24-000212 · form4.xml · derivative · entry 3 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 5,352,746 Underlying: Class A Common Stock · 5,352,746 shares Expires 2029-01-16 F9 · derivative.exercise_price: The actual exercise price for these warrants is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F1 · kind: On January 12, 2024, the Issuer entered into a securities purchase agreement (the "Securities Purchase Agreement") with Dragasac Limited ("Dragasac"), pursuant to which Dragasac agreed to deliver $6.0 million to the Issuer in exchange for 21,410,983 shares of Class A Common Stock and warrants to purchase up to 5,352,746 shares of Class A Common Stock. The actual price for the 21,410,983 shares of Class A Common Stock is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F1 · price: On January 12, 2024, the Issuer entered into a securities purchase agreement (the "Securities Purchase Agreement") with Dragasac Limited ("Dragasac"), pursuant to which Dragasac agreed to deliver $6.0 million to the Issuer in exchange for 21,410,983 shares of Class A Common Stock and warrants to purchase up to 5,352,746 shares of Class A Common Stock. The actual price for the 21,410,983 shares of Class A Common Stock is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F6 · ownership.nature: These securities are directly held by Dragasac, which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 17:22 UTC | Celularity Inc CELU · Entity 7145 | PurchaseClass A Common Stock | 21,410,983 | $0.25 | $5,331,334.77 |
DisclosureSEC source: 0000905148-24-000212 · form4.xml · nonDerivative · entry 1 Lim Kok Thay · CIK 0001470308 · 10% owner Dragasac Ltd · CIK 0001872884 · 10% owner Genting Berhad · CIK 0001788489 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Dragasac Limited Disclosed balance after: 51,473,762 F1 · kind: On January 12, 2024, the Issuer entered into a securities purchase agreement (the "Securities Purchase Agreement") with Dragasac Limited ("Dragasac"), pursuant to which Dragasac agreed to deliver $6.0 million to the Issuer in exchange for 21,410,983 shares of Class A Common Stock and warrants to purchase up to 5,352,746 shares of Class A Common Stock. The actual price for the 21,410,983 shares of Class A Common Stock is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F1 · price: On January 12, 2024, the Issuer entered into a securities purchase agreement (the "Securities Purchase Agreement") with Dragasac Limited ("Dragasac"), pursuant to which Dragasac agreed to deliver $6.0 million to the Issuer in exchange for 21,410,983 shares of Class A Common Stock and warrants to purchase up to 5,352,746 shares of Class A Common Stock. The actual price for the 21,410,983 shares of Class A Common Stock is $0.24898 per share of Class A Common Stock, which has been rounded due to systematic character limitations. F6 · ownership.nature: These securities are directly held by Dragasac, which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Each of Genting Berhad and Mr. Lim disclaims beneficial ownership over these securities except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.